Evidence map›Paper›PMID 30342822›Full record

ArticleAntiviral research2018

Protease inhibitors broadly effective against feline, ferret and mink coronaviruses.

Krishani Dinali Perera, Anushka C Galasiti Kankanamalage, Athri D Rathnayake, Amanda Honeyfield, William Groutas, Kyeong-Ok Chang, Yunjeong Kim

Abstract read
In one paragraph

Article in Antiviral research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Crystallization of Feline Coronavirus MFrontiers in chemistry · 2022
    Article
  9. Article
  10. Article
  11. Improved SARS-CoV-2 MEuropean journal of medicinal chemistry · 2021
    Review
  12. Article
  13. SARS-CoV-2 Seroprevalence in Household Domestic Ferrets (Animals : an open access journal from MDPI · 2021
    Article
  14. Review
  15. COVID-19: What Should the General Practitioner Know?Clinical interventions in aging · 2021
    Review
  16. Nanotechnology-based therapeutic formulations in the battle against animal coronaviruses: an update.Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology · 2021
    Review
  17. Article
  18. Review
  19. Article
  20. Persistent infection and pancytopenia associated with ferret systemic coronaviral disease in a domestic ferret.Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Krishani Dinali PereraDepartment of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
Anushka C Galasiti KankanamalageDepartment of Chemistry, Wichita State University, Wichita, KS, USA.
Athri D RathnayakeDepartment of Chemistry, Wichita State University, Wichita, KS, USA.
Amanda HoneyfieldDepartment of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
William GroutasDepartment of Chemistry, Wichita State University, Wichita, KS, USA.
Kyeong-Ok ChangDepartment of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
Yunjeong KimDepartment of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA. Electronic address: ykim@vet.ksu.edu.
Kansas State University · USWichita State University · US

Funding

SARS-CoV Proteins in Heterologous Viral InfectionP01AI060699 · NIAID · UNIVERSITY OF IOWA · PI PERLMAN, STANLEY · 2004 to 2021
$21.5M
Small Molecule Protease Inhibitors against MERS-CoV and Coronaviruses of Pandemic PotentialR01AI130092 · NIAID · KANSAS STATE UNIVERSITY · PI Kyeong-Ok Chang, William Constantine Groutas · 2018 to 2026
$5.9M
Role of eicosanoids in pathogenic human CoV infectionsR01AI129269 · NIAID · UNIVERSITY OF IOWA · PI Stanley Perlman · 2016 to 2026
$4.7M
NIAID NIH HHS P01 AI060699NIAID NIH HHS R01 AI129269NIAID NIH HHS R01 AI130092
6 · The paper itself

Abstract

Ferret and mink coronaviruses typically cause catarrhal diarrhea in ferrets and minks, respectively. In recent years, however, systemic fatal coronavirus infection has emerged in ferrets, which resembles feline infectious peritonitis (FIP) in cats. FIP is a highly fatal systemic disease caused by a virulent feline coronavirus infection in cats. Despite the importance of coronavirus infections in these animals, there are no effective commercial vaccines or antiviral drugs available for these infections. We have previously reported the efficacy of a protease inhibitor in cats with FIP, demonstrating that a virally encoded 3C-like protease (3CLpro) is a valid target for antiviral drug development for coronavirus infections. In this study, we extended our previous work on coronavirus inhibitors and investigated the structure-activity relationships of a focused library of protease inhibitors for ferret and mink 3CLpro. Using the fluorescence resonance energy transfer assay, we identified potent inhibitors broadly effective against feline, ferret and mink coronavirus 3CLpro. Multiple amino acid sequence analysis and modelling of 3CLpro of ferret and mink coronaviruses were conducted to probe the structural basis for these findings. The results of this study provide support for further research to develop broad-spectrum antiviral agents for multiple coronavirus infections. To the best of our knowledge, this is the first report on small molecule inhibitors of ferret and mink coronaviruses.

Indexed as

3C Viral ProteasesAnimalsAntiviral AgentsCatsCoronavirusCysteine EndopeptidasesFerretsFluorescence Resonance Energy TransferMinkMolecular Docking SimulationProtease InhibitorsStructure-Activity RelationshipViral Proteins3C Viral ProteasesAntiviral AgentsCysteine EndopeptidasesProtease InhibitorsViral Proteins3C-like proteaseFeline coronavirusFerret coronavirusMink coronavirusProtease inhibitor

Identifiers

PMID30342822
PMCPMC6240502
OpenAlexW2896460263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.